The pharmacological management of depression – Update 2017
Depression affects nearly 350 million people worldwide. Local data indicates that approximately 17% of all South Africans will experience at least one episode of depression in their lifetime. Depressive disorders contribute significantly towards overall morbidity and increased risk for suicide. Anti...
Saved in:
| Main Authors: | Elzbieta Osuch, Andre Marais |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2017-03-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4625 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?
by: Sueki A, et al.
Published: (2016-05-01) -
Oxidant/Antioxidant Equilibrium and Neurotransmitter Levels in Camelids Used for Circus Activities: A Preliminary Study
by: Raffaella Cocco, et al.
Published: (2025-06-01) -
Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system
by: Annelies Heylen, et al.
Published: (2025-01-01) -
Unraveling the Serotonergic Mechanism of Stress-Related Anxiety: Focus on Co-Treatment with Resveratrol and Selective Serotonin Reuptake Inhibitors
by: Vadim E. Tseilikman, et al.
Published: (2024-10-01) -
Hormonal and Psychological Responses to a Single Cold-Water Immersion in Regularly Winter-Swimming Males
by: Aneta Teległów, et al.
Published: (2025-06-01)